DiaMedica Therapeutics Inc.
DMAC· Nasdaq
Released Nov 13, 2024, after the close
10-Q filed Nov 13, 2024, 44 days after period end · 0001437749-24-034925
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$6.27M | -$4.47M | -$3.06M | -$3.45M |
| EPS Diluted | — | — | — | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DiaMedica Therapeutics Inc. · CIK 1401040 · Engraved from SEC EDGAR